What is AngioDynamics?
Established in 1988 as a division of E-Z-EM, AngioDynamics has cultivated a rich history defined by innovation and growth as a dedicated partner to the medical community. The company focuses on developing high-quality medical devices engineered to enhance patient outcomes. AngioDynamics boasts a notable global presence, with operations spanning worldwide. Through strategic alliances, robust distribution channels, and a diverse product portfolio, AngioDynamics consistently contributes to the advancement of medical solutions and the improvement of patient care across key international healthcare markets.
How much funding has AngioDynamics raised?
AngioDynamics has raised a total of $376.4M across 3 funding rounds:
Stock Offering
$21.4M
Debt
$250M
Debt
$105M
Stock Issuance/Offering (2004): $21.5M, investors not publicly disclosed
Debt (2016): $250M, investors not publicly disclosed
Debt (2022): $105M, investors not publicly disclosed
What's next for AngioDynamics?
The recent major strategic investment signifies AngioDynamics' intent to further solidify its market position and potentially expand its product development pipeline or global reach. Given the company's history of innovation and its established presence in key healthcare markets, this capital infusion is likely to fuel strategic initiatives aimed at enhancing its portfolio of medical devices. Future endeavors may include research and development for next-generation technologies, acquisitions to broaden its offerings, or strengthening its distribution networks to reach a wider patient base. The company's trajectory suggests a continued focus on improving patient outcomes through advanced medical solutions.
See full AngioDynamics company page
